-
Science Saturday: Regenerative medicine in novel fetal therapy program
Share this:
Specialists at Mayo Clinic are pioneering a life-saving procedure as part of a clinical trial for babies with congenital diaphragmatic hernia (CDH).
When a baby’s lungs are not adequately developed at birth, severe complications and even death can result. Waiting for the baby to be born to intervene may be too late. A new study is underway to document fetal lung growth from early intervention before birth.
CDH develops when a baby’s chest cavity is compressed and lung development is restricted because the diaphragm does not close completely and the abdominal organs push into the chest cavity. CDH is a life-threatening condition affecting 1 in 2,500 births. Read the rest of the article on the Center for Regenerative Medicine blog.
___________________________________________
Other Mayo Clinic medical research websites:
- Research at Mayo Clinic
- Discovery’s Edge
- Advancing the Science
- Forefront
- Mayo Clinic Center for Individualized Medicine
- Mayo Clinic Center for Innovation
- Center for Regenerative Medicine
- Center for the Science of Health Care Delivery
Share this:
Related articles
The Food and Drug Administration is expected to decide by Dec. 8 on a new therapy to treat sickle cell disease using gene editing technology called CRISPR, ...
"My ear hurts." There are many conditions that can trigger this complaint from a young child. Depending on the symptoms, causes of earache in children ...
November is National Epilepsy Awareness Month, which makes this a good time to learn about epilepsy in children. Epilepsy, also known as seizure disorder, is common, ...